Lung Diseases Clinical Trial
To address the public health importance of sleep disordered breathing and ultimately reduce morbidity through information gained from longitudinal, population-based, epidemiologic studies.
BACKGROUND:
The investigators have shown that undiagnosed sleep disordered breathing is prevalent for
both men and women throughout the range of middle age; multidisciplinary research findings
suggest that untreated sleep disordered breathing may lead to significant behavioral and
cardiovascular morbidity. The relative risks are of direct application to public health
estimates of: How much behavioral and cardiovascular morbidity would be eliminated if
prevalence of untreated sleep disordered breathing were significantly reduced? How much
reduction in sleep disordered breathing prevalence could be achieved by eliminating the
modifiable etiologic factors? Should high risk groups be targeted for early detection of
risk factor reduction programs?
DESIGN NARRATIVE:
The study quantified the etiologic role of hypothesized risk factors for sleep disordered
breathing, described progression of the pathophysiologic process, and tested causal
hypotheses of adverse health outcomes. The study was conducted on a unique, established
cohort of over 800 subjects, representative of middle-aged employed adults. Extensive
baseline polysomnographic and other data were available on the established cohort of 800
subjects; additional cohorts of 50 perimenopausal women and 200 older adults were added for
maximum study power. The research resulted in longitudinal data, over a 5-9 year period, on
multiple parameters of sleep, breathing, risk factors and outcomes. The independent relative
risks were calculated with multivariate techniques to express the temporal relationships for
sleep disordered breathing etiologic factors and for consequences of sleep disordered
breathing.
The study was renewed in 1993 and used longitudinal studies to focus on specific questions
of greatest relevance to public health, namely: the roles of aging and menopause in the
development of sleep-disordered breathing and the effect of sleep disordered breathing on
hypersomnolence and systemic hypertension.
The study completion date listed in this record was obtained from the "Completed Date"
entered in the Query View Report System (QVR).
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A |